PPARD and Parkinson disease: The neuroprotective action of PPARβ/δ antagonist in the PD cellular model may be due to increased neuronal survival that requires neurotrophic support, mainly BDNF but may be attributable also to a general decrease of oxidative stress by the antagonist, since it is already reported that high levels of oxidative stress are responsible for a decrease of the neurotrophic support.